HI
DXCM icon

HBK Investments’s DexCom DXCM Stock Holding History

HBK Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-88,307
Closed -$8.24M – 229
2023
Q3 		$8.24M Buy
88,307
+28,238
+47% +$3.18M 0.04% 90
2023
Q2 		$7.72M Buy
+60,069
New +$7.27M 0.04% 80
2022
Q4 		– Sell
-23,624
Closed -$1.9M – 83
2022
Q3 		$1.9M Buy
23,624
+2,640
+13% +$224K 0.01% 303
2022
Q2 		$1.56M Sell
20,984
-36,976
-64% -$3.37M 0.01% 373
2022
Q1 		$7.41M Buy
57,960
+13,324
+30% +$1.46M 0.03% 160
2021
Q4 		$5.99M Buy
+44,636
New +$6.41M 0.02% 222
2019
Q2 		– Sell
-151,200
Closed -$4.5M – 730
2019
Q1 		$4.5M Sell
151,200
-102,368
-40% -$3.6M 0.05% 344
2018
Q4 		$7.59M Buy
253,568
+193,568
+323% +$6.14M 0.08% 194
2018
Q3 		$2.15M Buy
+60,000
New +$1.86M 0.02% 512
2016
Q2 		– Sell
-25,312
Closed -$430K – 990
2016
Q1 		$430K Sell
25,312
-234,460
-90% -$3.92M ﹤0.01% 761
2015
Q4 		$5.32M Buy
259,772
+60,060
+30% +$1.25M 0.05% 205
2015
Q3 		$4.29M Buy
199,712
+164,112
+461% +$3.66M 0.04% 258
2015
Q2 		$712K Sell
35,600
-240,620
-87% -$4.23M 0.01% 646
2015
Q1 		$4.3M Buy
276,220
+99,420
+56% +$1.5M 0.04% 263
2014
Q4 		$2.43M Buy
176,800
+67,200
+61% +$823K 0.03% 346
2014
Q3 		$1.1M Buy
+109,600
New +$1.12M 0.02% 521
2014
Q2 		– Sell
-90,800
Closed -$939K – 950
2014
Q1 		$939K Buy
+90,800
New +$939K 0.02% 512
2013
Q4 		– Sell
-45,600
Closed -$322K – 924
2013
Q3 		$322K Buy
+45,600
New +$289K ﹤0.01% 732

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HBK Investments's DXCM Position: Q4 2023 in Review

HBK Investments sold out of DexCom (DXCM) in Q4 2023, closing a stake of 88,307 shares — an estimated $8.24M sold.

HBK Investments first reported a position in DXCM in Q3 2013 and held it in 18 quarters. The position peaked at $8.24M in Q3 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • HBK Investments reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • HBK Investments sold 88,307 DexCom shares in Q4 2023, an estimated $8.24M.
  • HBK Investments first reported a position in DexCom in Q3 2013 and held it in 18 quarters.
  • HBK Investments's DexCom position peaked at $8.24M in Q3 2023.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on HBK Investments's 13F filing for Q4 2023, filed 14 Feb 2024.